Is the Chinese vaccine really ineffective for the elderly? WHO says the opposite

Change language:

The World Health Organisation (WHO) has confirmed that China’s Sinopharm vaccine is effective also in protecting the elderly against Covid-19, a foreign ministry official said on Tuesday. Sinopharm was the vaccine the Hungarian opposition attacked the most saying that it is unsafe and ineffective. They stressed that the Chinese product should only be used after it received the approval of the European Medicine Agency.

Tamás Menczer, the state secretary for communications and international representation, said in a video message on Facebook that WHO released earlier in the day its

detailed recommendations on Sinopharm.

Menczer quoted WHO as saying that based on currently available data it recommends using the Chinese vaccine also for the inoculation of people aged older than 60. WHO said it had no data suggesting any difference in the effect of Sinopharm on people in older or younger age groups, the state secretary added.

WHO, Menczer noted, announced on May 7 that it had approved the Chinese vaccine as effective and safe.

As we reported before, István Tényi, formerly a member of the currently governing Fidesz party, has filed a report to the Hungarian National Bureau of Investigation on suspicion of

criminal misconduct related to the acquisition of the Sinopharm vaccines.

The company that executed the shipping of the Chinese vaccines to Hungary, namely the Danubia Pharma LLC, has an obscure ownership structure, and according to Tényi and the news agency’s point of view, there should not have been any payment to a company without proper transparency from the central budget under the Fundamental Law of Hungary.

Continue reading

2 Comments

  1. Safety data are limited for persons above 60 years of age (due to the small number of participants in clinical trials). While no differences in safety profile of the vaccine in older adults compared to younger age groups can be anticipated, countries considering using this vaccine in persons older than 60 years should maintain active safety monitoring.
    The vaccine is not recommended for persons younger than 18 years of age, pending the results of further studies in that age group.
    The trial was not designed and powered to demonstrate efficacy against severe disease in persons with comorbidities, in pregnancy, or in persons aged 60 years and above. Women were underrepresented in the trial. The median duration of follow-up available at the time of evidence review was 112 days.
    This extract was taken from the WHO report published two days ago.
    The Sinopharm COVID-19 vaccine: What you need to know
    This is the title if anyone wishes to read it for themselves.
    It would appear to be a safe vaccine, as much as any other, it’s just the government goes a bit over the top in trying to promote it.

  2. The REAL question remains unanswered : will those “bunkó” politicians in the Hungarian opposition ‘sausage party’ ever APOLOGISE for misleading voters in regards to numerous FALSE comments they made about Sinopharm COVID-19 vaccine (and thereby maybe causing the DEATHS of some Hungarians)?

    As the old saying goes, “Pigs will fly in Mecca during the month of Ramadan” before such a monumentous event happens.

    There were no recent sightings of airborne porcine creatures reported from Saudi Arabia so it can only be assumed that the politicians in question have decided that ‘it is better to keep quiet and be thought as stupid than opening (their) mouth(s) and removing all doubt’.

    What a shame they didn’t follow such sensible advice earlier ……

Leave a Reply

Your email address will not be published. Required fields are marked *